0001140361-21-042237.txt : 20211217
0001140361-21-042237.hdr.sgml : 20211217
20211217164137
ACCESSION NUMBER: 0001140361-21-042237
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210817
FILED AS OF DATE: 20211217
DATE AS OF CHANGE: 20211217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
FISCAL YEAR END: 0531
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56199
FILM NUMBER: 211502183
BUSINESS ADDRESS:
STREET 1: 655 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 519.322.8800
MAIL ADDRESS:
STREET 1: 655 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MedMen Enterprises, Inc.
CENTRAL INDEX KEY: 0001776932
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990]
IRS NUMBER: 981431779
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 10115 JEFFERSON BOULEVARD
CITY: CULVER CITY
STATE: CA
ZIP: 90232
BUSINESS PHONE: 4243302082
MAIL ADDRESS:
STREET 1: 10115 JEFFERSON BOULEVARD
CITY: CULVER CITY
STATE: CA
ZIP: 90232
3
1
form3.xml
FORM 3
X0206
3
2021-08-17
0
0001776932
MedMen Enterprises, Inc.
MMNFF
0001731348
Tilray, Inc.
655 MADISON AVENUE
SUITE 1900
NEW YORK
NY
10065
true
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
20857737.28
I
See Footnote
Convertible Note
0.17
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
26263572.01
I
See Footnote
Convertible Note
0.34
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
24387602.58
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
89830505.79
I
See Footnote
Convertible Note
0.17
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
113112459.23
I
See Footnote
Convertible Note
0.34
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
105032997.86
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
29211057.26
I
See Footnote
Convertible Note
0.17
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
36781875.98
I
See Footnote
Convertible Note
0.34
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
34154599.12
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
21353535.67
I
See Footnote
Convertible Note
0.17
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
26887869.68
I
See Footnote
Convertible Note
0.34
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
24967307.56
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
11311119.62
I
See Footnote
Convertible Note
0.17
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
14242695.68
I
See Footnote
Convertible Note
0.34
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
13225360.28
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
111596680.65
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
14931229.66
I
See Footnote
Convertible Note
0.2845
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
5365563.91
I
See Footnote
Convertible Note
0.1529
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
28874592.48
I
See Footnote
Convertible Note
0.1608
2021-08-17
2028-08-17
Class B Subordinate Voting Shares
53395928.68
I
See Footnote
The convertible notes and warrants are owned directly by Superhero Acquisition L.P. ("LP"). Superhero Acquisition Corp. ("Corp.") is the general partner of LP. Tilray, Inc. ("Tilray") owns approximately two-thirds of the outstanding equity interests in Corp. and approximately two-thirds of the outstanding equity interest in LP. Accordingly, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Tilray may be deemed a beneficial owner with respect to securities held of record by LP and has shared voting and investment power with respect to such securities. Tilray disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
This Form 3 is one of two Form 3s filed relating to the same event. This Form 3 has been split into two filings because there are more than 30 derivative securities beneficially owned, and the SEC's EDGAR filing system limits a single Form 3 to a maximum of 30 rows per table. This filing relates to transactions that occurred on August 17, 2021, which were previously disclosed by Tilray in its Current Report on Form 8-K filed on August 18, 2021. As of the date of this filing, Tilray has not executed any transactions in MedMen Enterprises, Inc. securities since August 17, 2021.
/s/ Mitchell Gendel, authorized officer
2021-12-17